<DOC>
	<DOCNO>NCT02177370</DOCNO>
	<brief_summary>The aim study compare effect fenoterol meter dose inhaler disodium cromoglycate ( DSCG ) meter dose inhaler lymphocyte β2-receptor population well clinical finding patient bronchial asthma two-week period treatment .</brief_summary>
	<brief_title>Effect Fenoterol Metered Dose Inhaler Beta-receptor Population Lymphocytes Patients With Bronchial Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fenoterol</mesh_term>
	<criteria>sex : male female age : 18 year bronchial asthma , diagnosis confirm history positive inhalation challenge test ( unspecific challenge carbachol , PD100SRaw ) ) severity asthma mild moderate asthmatic symptomfree interval Raw ≤ 5 cm H2O/l/s antiasthmatic treatment week ( steroid therapy : two week ) start study clinically significant , concomitant haematological , cardiac , renal , hepatic metabolic diseases intercurrent disease , e.g . severe respiratory infection patient without follow preparation 5week trial : inhaled/oral steroid theophylline antihistamine , antiallergic drug inhaled/oral sympathomimetics anticholinergic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>